Skip to content

Prevention of postoperative pneumonia by antimicrobial pharmacy administration in intubated patients after oral surgery: a preliminary study

Prevention of postoperative pneumonia by antimicrobial pharmacy administration in intubated patients after oral surgery: a preliminary study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs071230007
Enrollment
10
Registered
2023-04-14
Start date
2023-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubated patients after oral surgery Oral surgery

Interventions

One application of tetracycline hydrochloride ointment on the back of the tongue.
topical antibiotics administration

Sponsors

Miura Kei-ichiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Oral surgery patients who are managed under intubation by postoperative tracheotomy at Nagasaki University Hospital Oral Surgery or Hiroshima University Hospital Oral and Maxillofacial Surgery between the date of jRCT publication and December 28, 2023. 2. Patients who can personally provide written consent at their own free will after being receiving a thorough explanation of the study and fully understanding their participation in the study.

Exclusion criteria

Exclusion criteria: Any of the following patients will be excluded: 1. Patients with past history of allergy for the tetracycline hydrochloride and ampicillin sodium sulbactam sodium 2. Partients who are judged to be inappropriate to participate the study by the principal or cooperative doctors.

Design outcomes

Primary

MeasureTime frame
Bacterial counts in oropharyngeal fluid and retained fluid on the cuff before administration and 1, 2, 3, and 6 hours after administration

Secondary

MeasureTime frame
1. Antimicrobial drug concentrations in oropharyngeal fluid and supra-cuff fluid before administration and 1, 2, 3, and 6 hours after administration 2. Development of postoperative pneumonia 3. Safety of antimicrobial pharmacy administration

Contacts

Public ContactKei-ichiro Miura

Nagasaki University Hospital

kei-miura@nagasaki-u.ac.jp+81-95-819-7698

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026